Jump to main content
eTG Complete
eTG Complete
Index
  1. Home
  2. Addiction
  3. Opioids: hazardous, harmful and dependent use
  4. Considerations for specific populations in management of disorders of opioid use
  • Addiction
    • What is covered in the Addiction guidelines?
    • Overview of substance use and addictive behaviours
    • Tobacco smoking and nicotine dependence
    • Alcohol: hazardous, harmful and dependent use
    • Opioids: hazardous, harmful and dependent use
      • What is covered in this topic?
      • Screening for and assessment of opioid use
      • Overview of management of disorders of opioid use
      • Opioid overdose
      • Overview of medication-assisted treatment of opioid dependence (MATOD)
      • Buprenorphine for medication-assisted treatment of opioid dependence (MATOD)
      • Methadone for medication-assisted treatment of opioid dependence (MATOD)
      • Considerations when stopping medication-assisted treatment of opioid dependence (MATOD)
      • Opioid withdrawal
      • Considerations for specific populations in management of disorders of opioid use
        • Management of opioid dependence during pregnancy
        • Management of opioid dependence during breastfeeding
      • References
    • Benzodiazepines, zolpidem and zopiclone: hazardous, harmful and dependent use
    • Cannabis: hazardous, harmful and dependent use
    • Gamma-hydroxybutyrate (GHB): hazardous, harmful and dependent use
    • Hallucinogens: hazardous and harmful use
    • Ketamine: hazardous and harmful use
    • Pregabalin and gabapentin: hazardous, harmful and dependent use
    • Quetiapine and other antipsychotics: hazardous, harmful and dependent use
    • Sedating antihistamines: hazardous, harmful and dependent use
    • Stimulants: hazardous, harmful and dependent use
    • Volatile inhalants: hazardous, harmful and dependent use
    • Addictive behaviours
    • Key resources for substance use and addictive behaviours

Considerations for specific populations in management of disorders of opioid use

Unmanaged opioid use during pregnancy or breastfeeding is associated with harms; specific considerations apply in managing opioid dependence in both patient groups, including the need for urgent specialist referral. For other groups, see Considerations for specific populations in substance use and addictive behaviours.

  • Management of opioid dependence during pregnancy
  • Management of opioid dependence during breastfeeding
  • Contact us
  • Conditions of use and disclaimer
  • Privacy policy
  • Copyright permission
  • Support and FAQ

www.tg.org.au
All site content © Therapeutic Guidelines Limited 2020. Therapeutic Guidelines Limited, Ground Floor, 473 Victoria Street, West Melbourne, Victoria 3003, Australia © Therapeutic Guidelines Ltd (eTG August 2020)

Created: No created attribute found. Modified: No revised attribute found. (HW Diagnostics)